Back
Acute kidney injury (AKI) is a common complication in cancer patients. This multifactorial condition often leads to longer hospital stay, discontinuation of cancer treatment, and poor prognosis. This study aimed to provide insight into the incidence of severe AKI in cancer patients and to identify the risk factors associated with renal replacement therapy (RRT) and mortality.
This was a retrospective cohort study involving 3201 patients with cancer and severe AKI admitted to a Comprehensive Cancer Center between January 1995 and July 2023. Severe AKI was defined according to the KDIGO guidelines as grade ≥ 2 AKI with nephrological in-hospital follow-up. Patients without indications for cardiopulmonary resuscitation or those previously referred for palliative care were excluded. Data were collected from the electronic medical records and analyzed using SPSS® 26.0.
To the best of our knowledge, this is one of the few studies addressing the demographic and clinical features of cancer patients with severe AKI. We created a prediction model for RRT and in-hospital mortality, and a risk score for hemato-oncological and all patients’ mortality.